Showing 81-100 of 197 for: Cochrane Systematic Reviews > Hematologic 
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 17-Mar-2010
Cytomegalovirus (CMV) is the most common virus causing disease and death in solid organ transplant recipients during the first six months post-transplant. Previous systematic reviews have demonstrated the efficacy of antiviral medications used prophylacti
- Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies
Cochrane Systematic Reviews, 17-Apr-2012
Serum monoclonal anti-myelin-associated glycoprotein antibodies may be pathogenic in some people with immunoglobulin M (IgM) paraprotein and demyelinating neuropathy. Immunotherapies aimed at reducing the level of these antibodies might be expected to be
- Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease
Cochrane Systematic Reviews, 2-Dec-2022
Bronchodilators are used to treat bronchial hyper-responsiveness in asthma. Bronchial hyper-responsiveness may be a component of acute chest syndrome in people with sickle cell disease. Therefore, bronchodilators may be useful in the treatment of acute ch
- Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease
Cochrane Systematic Reviews, 24-Jan-2013
Acute chest syndrome has been defined as a new infiltrate visible on chest radiograph associated with one or more symptoms, such as fever, cough, sputum production, tachypnoea, dyspnoea, or new-onset hypoxia. Symptoms and complications of this syndrome, w
- Inhaled non‐steroid anti‐inflammatories for children and adults with bronchiectasis
Cochrane Systematic Reviews, 27-Jan-2016
Chronic neutrophilic inflammation, in both the presence and absence of infection, is a feature of bronchiectasis in adults and children. The anti-inflammatory properties of non-steroid anti-inflammatory drugs (NSAIDs) may be beneficial in reducing airway
- Insecticide-treated bed nets and curtains for preventing malaria
Cochrane Systematic Reviews, 17-Feb-2009
Malaria is an important cause of illness and death in many parts of the world, especially in sub-Saharan Africa. There has been a renewed emphasis on preventive measures at community and individual levels. Insecticide-treated nets (ITNs) are the most prom
- Intermittent iron supplementation for improving nutrition and development in children under 12 years of age
Cochrane Systematic Reviews, 5-Mar-2014
Approximately 600 million children of preschool and school age are anaemic worldwide. It is estimated that half of the cases are due to iron deficiency. Consequences of iron deficiency anaemia during childhood include growth retardation, reduced school ac
- Interventions for preventing and treating kidney disease in Henoch‐Schönlein Purpura (HSP)
Cochrane Systematic Reviews, 7-Aug-2015
Henoch-Schönlein purpura (HSP) is the most common vasculitis of childhood but may occur in adults. This small vessel vasculitis is characterised by palpable purpura, abdominal pain, arthritis or arthralgia and kidney involvement. This is an update of a re
- Interventions for reducing the risk of mother-to-child transmission of HIV infection
Cochrane Systematic Reviews, 5-Sep-2011
PLEASE NOTE: This review should be considered obsolete and outdated. Instead of this review, please refer to the following Cochrane reviews:
- Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals
Cochrane Systematic Reviews, 12-Dec-2012
Squamous cell carcinoma of the conjunctiva is described in the ophthalmic literature as a rare, slow-growing tumour of the eye, normally affecting elderly men around 70 years of age. In Africa, however, the disease is different. The incidence is rising ra
- Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children
Cochrane Systematic Reviews, 6-Oct-2010
Oral candidiasis (OC) associated with human immunodeficiency virus (HIV) infection occurs commonly and recurs frequently, often presenting as an initial manifestation of the disease. Left untreated, these lesions contribute considerably to the morbidity a
- Interventions for the treatment of decreased bone mineral density associated with HIV infection
Cochrane Systematic Reviews, 10-Nov-2008
Decreased bone mineral density (BMD) occurs more commonly in patients with HIV than in the general population, making this group more susceptible to fragility fractures. However, bone loss is under-treated in patients with HIV.
- Interventions for toxic epidermal necrolysis
Cochrane Systematic Reviews, 17-Feb-2015
Toxic epidermal necrolysis is a rare condition where a drug reaction induces skin loss, similar to that seen in extensive burns. It is associated with high morbidity and mortality and there is no clear agreement on effective treatment.
- Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adults
Cochrane Systematic Reviews, 5-Sep-2011
Hodgkin's disease (HD) is the most common non-AIDS-defining malignancy in HIV-infected patients. Its unusually aggressive tumour behaviour includes a higher frequency of unfavourable histologic subtypes, high-stage and extranodal involvement by the time o
- Interventions for treating oral mucositis for patients with cancer receiving treatment
Cochrane Systematic Reviews, 6-Sep-2010
Treatment of cancer is increasingly effective but associated with short and long term side effects. Oral side effects, including oral mucositis (mouth ulceration), remain a major source of illness despite the use of a variety of agents to treat them.
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 20-Dec-2013
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This revie
- Intravenous immunoglobulin for Guillain-Barré syndrome
Cochrane Systematic Reviews, 19-Sep-2014
Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 200
- Intravenous immunoglobulin for multifocal motor neuropathy
Cochrane Systematic Reviews, 3-Nov-2008
Multifocal motor neuropathy is a rare, probably immune mediated disorder characterised by slowly progressive, asymmetric, distal weakness of one or more limbs with no objective loss of sensation. It may cause prolonged periods of disability. The treatment
- Intravenous immunoglobulin for myasthenia gravis
Cochrane Systematic Reviews, 14-Nov-2012
Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous immunoglobulin (IVIg). This is an
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults
Cochrane Systematic Reviews, 5-May-2015
This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace.
